ENTITY
Samsung Pharmaceutical

Samsung Pharmaceutical (001360 KS)

6
Analysis
Health Care • South Korea
Samsung Pharmaceutical Co., Ltd. manufactures medicines to treat a variety of diseases. The Company's products include medicines for inflammatory, nutrition, and digestive system.
more
bullish•Samsung Electronics
•10 Jan 2024 18:36

Samsung Electronics Placement - Somewhat Well Flagged but Could Have Timed It Better

KEB Hana Bank, on behalf of the Lee family, is looking to raise up to US$1.6bn via selling 0.5% of Samsung Electronics (005930 KS)

Logo
1k Views
Share
bearish•Quantitative Analysis
•04 Sep 2019 07:06

Korea Short Interest - SillaJen Tends to Zero

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 30 August.Current...

Logo
592 Views
Share
•08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.1k Views
Share
•07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.6k Views
Share
bullish•Samsung C&T Corp/Old
•06 Jul 2015 00:14

C&T/Cheil: Proposed Inconsistencies & Magical Arithmetic

On June 30, Samsung C&T sent a letter to shareholders. That letter talked about the "significant business challenges and industry headwinds."...

Logo
639 Views
Share
x